1. UK Health Security Agency. Annual epidemiological commentary: gram-negative, MRSA, MSSA bacteraemia and C. difficile infections, up to and including financial year 2022 to 2023; 2023. Available from: 〈https://www.gov.uk/government/statistics/mrsa-mssa-and-e-coli-bacteraemia-and-c-difficile-infection-annual-epidemiological-commentary/annual-epidemiological-commentary-gram-negative-mrsa-mssa-bacteraemia-and-c-difficile-infections-up-to-and-including-financial-year-2022-to-2023〉.
2. Continued increases in the incidence of healthcare-associated infection (HAI) during the second year of the coronavirus disease 2019 (COVID-19) pandemic;Lastinger;Infect Control Hosp Epidemiol,2023
3. The impact of coronavirus disease 2019 (COVID-19) on healthcare-associated infections;Baker;Clin Infect Dis,2022
4. Epidemiology of Gram-negative bacteria during coronavirus disease 2019. What is the real pandemic?;Brink;Curr Opin Infect Dis,2022
5. National surveillance of bacterial and fungal coinfection and secondary infection in COVID-19 patients in England: lessons from the first wave;Gerver;Clin Microbiol Infect,2021